Integrated MALDI-MSI and Glycopeptide LC-MS/MS Reveal Site-and Region-Specific Glycosylation Changes in Tumor Tissue

Posters | 2025 | Bruker | ASMSInstrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Ion Mobility, MALDI, MS Imaging
Industries
Proteomics , Clinical Research
Manufacturer
Bruker
Downloadable PDF for viewing
 

Similar PDF

MALDI FTMS Imaging Mass Spectrometry of N-glycans as Tissue Biomarkers of Cancer
MALDI-2 for enhanced in situ N-glycan analysis
Integrated mass spectrometry-based analysis of plasma glycoproteins and their glycan modifications
Evaluating Protein Glycosylation in Limited-Quantity Samples by HPAE-PAD